J.M. Tourani

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Yungan Tao, J. Biau, X.S. Sun et al. · Annals of Oncology · 2022 · 166 citations · Full text

Ii Trial, Radiation Medicine, Radiation Therapy +10

Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma.

D. Khayat, Christian Borel, J.M. Tourani et al. · Journal of Clinical Oncology · 1993 · 149 citations

Elevation of IgE in HIV-infected subjects: A marker of poor prognosis

Dominique Israël‐Biet, François Labrousse, J.M. Tourani et al. · Journal of Allergy and Clinical Immunology · 1992 · 133 citations · Full text

Primary Immunodeficiency, Viral Persistence, Medicine +11

Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study.

D. Machover, L Schwarzenberg, Emma Goldschmidt et al. · PubMed · 1982 · 117 citations

Gastric Adenocarcinomas, Surgical Oncology, Gastrointestinal Oncology +9

Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group.

J.M. Tourani, C. Pfister, J.F. Berdah et al. · Journal of Clinical Oncology · 1998 · 78 citations